Integrative gene set analysis: Application to platinum pharmacogenomics

OMICS A Journal of Integrative Biology

Volumn 18, Issue 1, 2014, Pages 34-41

  Fridley, Brooke L ^a   Abo, Ryan ^b   Tan, Xiang Lin ^c,d   Jenkins, Gregory D ^c   Batzler, Anthony ^c   Moyer, Ann M ^c   Biernacka, Joanna M ^c   Wang, Liewei ^d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c Mayo Clinic   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; CANCER RESISTANCE; CONTROLLED STUDY; GENE EXPRESSION; GENE FREQUENCY; GENE ONTOLOGY; GENE SILENCING; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; INTEGRATIVE GENE SET ANALYSIS; INTRACELLULAR TRANSPORT; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE TRAIT; RNA BINDING; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CHROMOSOMAL PROTEINS, NON-HISTONE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LAMIN TYPE B; MICROFILAMENT PROTEINS; MULTIGENE FAMILY; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, SMALL INTERFERING; TRANSCRIPTOME;

EID: 84893107986     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0099     Document Type: Article

References (46)

1. Abo R, Jenkins GD, Wang L, and Fridley BL. (2012). Identifying the genetic variation of gene expression using gene sets: Application of novel gene set eQTL approach to PharmGKB and KEGG. PLoS One 7, e43301
2. Ashburner M, Ball CA, Blake JA, et al. (2000). Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25, 25-29
3. Ballard DH, Cho J, and Zhao H. (2010). Comparisons of multimarker association methods to detect association between a candidate region and disease. Genet Epidemiol 34, 201-212
4. Biernacka JM, Jenkins GD, Wang L, Moyer AM, and Fridley BL. (2012). Use of the gamma method for self-contained gene-set analysis of SNP data. Eur J Hum Genet 20, 565-571
5. Campone M, Campion L, Roche H, et al. (2008). Prediction of metastatic relapse in node-positive breast cancer: Establishment of a clinicogenomic model after FEC100 adjuvant regimen. Breast Cancer Res Treat 109, 491-501
6. Chai HS, Sicotte H, Bailey KR, Turner ST, Asmann YW, and Kocher JP. (2009). GLOSSI: A method to assess the association of genetic loci-sets with complex diseases. BMC Bioinformat 10, 102
7. Davidian M, and Giltinan DM. (1995). Nonlinear Models for Repeated Measurement Data. Chapman & Hall, New York
8. De La Guardia C, Casiano CA, Trinidad-Pinedo J, and Baez A. (2001). CENP-F gene amplification and overexpression in head and neck squamous cell carcinomas. Head Neck 23, 104-112
9. Eichelbaum M, Altman RB, Ratain M, and Klein TE. (2009). New feature: Pathways and important genes from PharmGKB. Pharmacogenet Genomics 19, 403
10. Fridley BL, Batzler A, Li L, et al. (2011). Gene set analysis of purine and pyrimidine antimetabolites cancer therapies. Pharmacogenet Genomics 21, 701-712
11. Fridley BL, Jenkins GD, and Biernacka JM. (2010). Self-contained gene-set analysis of expression data: An evaluation of existing and novel methods. PLoS One 5, e12693
12. Fridley BL, Jenkins GD, Tsai YY, et al. (2012). Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. Cancer Epidemiol Biomarkers Prevent 21, 529-536
13. Gallant AR. (1987). Nonlinear Statistical Models. Wiley, New York
14. Gauderman WJ, Murcray C, Gilliland F, and Conti DV. (2007). Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 31, 383-395
15. Goeman JJ, and Buhlmann P. (2007). Analyzing gene expression data in terms of gene sets: Methodological issues. Bioinformatics 23, 980-987
16. Goeman JJ, Van De Geer SA, De Kort F, and Van Houwelingen HC. (2004). A global test for groups of genes: Testing association with a clinical outcome. Bioinformatics 20, 93-99
17. Guo SW, and Thompson EA. (1992). Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48, 361-372
18. Hewett M, Oliver DE, Rubin DL, et al. (2002). PharmGKB: The Pharmacogenetics Knowledge Base. Nucleic Acids Res 30, 163-165
19. Huang C, Tang H, Zhang W, et al. (2012). Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prevent 21, 166-175
20. Kanehisa M, and Goto S. (2000). KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27-30
21. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 38, D355-360
22. Klein TE, Chang JT, Cho MK, et al. (2001). Integrating genotype and phenotype information: An overview of the PharmGKB project. Pharmacogenetics Research Network and Knowledge Base. Pharmacogenomics J 1, 167-170
23. Kokkinakis DM, Liu X, and Neuner RD. (2005). Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): Implications to the therapy of pancreatic adenocarcinoma. Mol Cancer Therapeut 4, 1338-1348
24. Li L, Fridley B, Kalari K, et al. (2008). Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression. Cancer Res 68, 7050-7058
25. Li L, Fridley BL, Kalari K, et al. (2009). Gemcitabine and arabinosylcytosin pharmacogenomics: Genome-wide association and drug response biomarkers. PLoS One 4, e7765
26. Liu H, Zhang J, Wang S, et al. (2012). Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system. Cancer Epidemiol 36, 82-88
27. Lu C, Spitz MR, Zhao H, et al. (2006). Association between glutathione S-Transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer 106, 441-447
28. Mardia KV, Kent JT, and Bibby JM. (1979). Multivariate Analysis. Academic Press, London
29. Meijer C, Timmer A, De Vries EG, et al. (2000). Role of metallothionein in cisplatin sensitivity of germ-cell tumours. Int J Cancer 85, 777-781
30. Moss SF, Krivosheyev V, De Souza A, et al. (1999). Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 45, 723-729
31. Niu N, Qin Y, Fridley BL, et al. (2010). Radiation pharmacogenomics: A genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Res 20, 1482-1492
32. Okcu MF, Selvan M, Wang LE, et al. (2004). Glutathione Stransferase polymorphisms and survival in primary malignant glioma. Clin Cancer Res 10, 2618-2625
33. Peters WA, 3rd, Liu PY, Barrett RJ, 2nd, et al. (2000). Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18, 1606-1613
34. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, and Reich D. (2006). Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38, 904-909
35. Sakano S, Wada T, Matsumoto H, et al. (2006). Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer 95, 561-570
36. Sorich MJ, Pottier N, Pei D, et al. (2008). In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile. PLoSMed 5, e83
37. Storey JD. (2002). A direct approach to false discovery rates. J Royal Statist Soc Series B 64, 479-498
38. Sun S, Xu MZ, Poon RT, Day PJ, and Luk JM (2010). Circulating Lamin B1 (LMNB1) biomarker detects early stages of liver cancer in patients. J Proteome Res 9, 70-78
39. Tan XL, Moyer AM, Fridley BL, et al. (2011). Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clin Cancer Res 17, 5801-5811
40. Tomfohr J, Lu J, and Kepler TB. (2005). Pathway level analysis of gene expression using singular value decomposition. BMC Bioinformatics 6, 225
41. Tyekucheva S, Marchionni L, Karchin R, and Parmigiani G. (2011). Integrating diverse genomic data using gene sets. Genome Biol 12, R105
42. Van Den Boom J, Wolter M, Kuick R, et al. (2003). Characterization of gene expression profiles associated with glioma progression using oligonucleotide-based microarray analysis and real-Time reverse transcription-polymerase chain reaction. Am J Pathol 163, 1033-1043
43. Van Der Straaten T, Kweekel D, Tiller M, Bogaartz J, and Guchelaar HJ. (2006). Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1. J Mol Diagn 8, 444-448
44. Vella N, Aiello M, Russo AE, et al. (2011). 'Genetic profiling' and ovarian cancer therapy (review). Mol Med Report 4, 771-777
45. Wigginton JE, Cutler DJ, and Abecasis GR. (2005). A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76, 887-893
46. Zaykin DV, Zhivotovsky LA, Czika W, Shao S, and Wolfinger RD. (2007). Combining p-values in large-scale genomics experiments. Pharm Stat 6, 217-226